135 results on '"Clémenty, Nicolas"'
Search Results
2. CRT-D replacement strategy: results of the BioCONTINUE study
3. Design of a post-market registry for the extravascular implantable cardioverter-defibrillator: the Enlighten Study
4. Utility of a guiding catheter for conduction system pacing: An early multicenter experience
5. Clinical Phenotypes and Atrial Fibrillation Recurrences After Catheter Ablation: An Unsupervised Cluster Analysis
6. Leadless cardiac pacing: Results from a large single-centre experience
7. Sex Differences in Outcomes of Tetralogy of Fallot Patients With Implantable Cardioverter-Defibrillators
8. Outcome of patients with early repolarization pattern and syncope
9. Genome-wide association analyses identify new Brugada syndrome risk loci and highlight a new mechanism of sodium channel regulation in disease susceptibility
10. Recurrences of Atrial Fibrillation Despite Durable Pulmonary Vein Isolation: The PARTY-PVI Study
11. Leadless pacemaker implant, anticoagulation status, and outcomes: Results from the Micra Transcatheter Pacing System Post-Approval Registry
12. Outcomes associated with pacemaker implantation following transcatheter aortic valve replacement: A nationwide cohort study
13. Age at diagnosis of Brugada syndrome: Influence on clinical characteristics and risk of arrhythmia
14. Prognosis of Type 2 Myocardial Infarction Patients Implanted With a Prophylactic Defibrillator (from the Very-High-Rate Registry)
15. Leadless Pacemaker Implantation in Hemodialysis Patients: Experience With the Micra Transcatheter Pacemaker
16. Strategies to improve atrioventricular synchrony in patients with a Micra AV leadless pacemaker.
17. Stroke, thromboembolism and bleeding in patients with atrial fibrillation according to the EHRA valvular heart disease classification
18. Author Correction: Genome-wide association analyses identify new Brugada syndrome risk loci and highlight a new mechanism of sodium channel regulation in disease susceptibility
19. Prediction of Incident Atrial Fibrillation According to Gender in Patients With Ischemic Stroke From a Nationwide Cohort
20. Subcutaneous Implantable Cardioverter-Defibrillators in Patients With Congenital Heart Disease
21. Three-dimensional interlead distance predicts response and outcomes after cardiac resynchronization therapy
22. Comparison of Outcome of Possible Versus Definite Infective Endocarditis Involving Native Heart Valves
23. The clinical and economic impact of extended battery longevity of a substernal extravascular implantable cardioverter defibrillator.
24. Causes of Death and Influencing Factors in Patients with Atrial Fibrillation
25. T Waves May Not Be What They Seem!
26. Position paper for management of elderly patients with pacemakers and implantable cardiac defibrillators: Groupe de Rythmologie et Stimulation Cardiaque de la Société Française de Cardiologie and Société Française de Gériatrie et Gérontologie
27. Oral Anticoagulation and the Risk of Stroke or Death in Patients With Atrial Fibrillation and One Additional Stroke Risk Factor: The Loire Valley Atrial Fibrillation Project
28. A leadless pacemaker in the real‐world setting: Patient profile and performance over time
29. How to define valvular atrial fibrillation?
30. The Impact of Associated Diabetic Retinopathy on Stroke and Severe Bleeding Risk in Diabetic Patients With Atrial Fibrillation: Th e Loire Valley Atrial Fibrillation Project
31. History of Thyroid Disorders in Relation to Clinical Outcomes in Atrial Fibrillation
32. Response to letter to the editor concerning the article "The clinical and economic impact of extended battery longevity of a substernal extravascular implantable cardioverter defibrillator".
33. Efficacy and Safety of an Extravascular Implantable Cardioverter–Defibrillator
34. Outcomes After Ablation for Typical Atrial Flutter (from the Loire Valley Atrial Fibrillation Project)
35. Prior History of Falls and Risk of Outcomes in Atrial Fibrillation: The Loire Valley Atrial Fibrillation Project
36. Programming implantable cardioverter-defibrillators in primary prevention: Higher or later
37. Prognosis in Patients Hospitalized With Permanent and Nonpermanent Atrial Fibrillation in Heart Failure
38. First in Human Substernal Lead Extraction
39. Comparison of Frequency of Major Adverse Events in Patients With Atrial Fibrillation Receiving Bare-Metal Versus Drug-Eluting Stents in Their Coronary Arteries
40. Left Retropectoral Axillary Implantation of Defibrillators in Young Women
41. MP-470545-001 INFECTION MANAGEMENT IN THE EXTRAVASCULAR IMPLANTABLE CARDIOVERTER DEFIBRILLATOR: EXPERIENCE FROM THE EV ICD PIVOTAL STUDY
42. PO-06-025 ATRIOVENTRICULAR LEADLESS PACEMAKER IMPLANT IN PATIENTS WITH PRIOR DEVICE INFECTIONS: RESULTS FROM THE MICRA AV POST-APPROVAL REGISTRY
43. Preventing atrial fibrillation by combined right isthmus ablation and cryoballoon pulmonary vein isolation in patients with typical atrial flutter: PAF‐CRIOBLAF study
44. PO-03-216 HYBRID VT ABLATION-SUBCUTANEOUS ICD MANAGEMENT STRATEGY FOR SECONDARY PREVENTION OF SUDDEN CARDIAC DEATH: THE VTABL-SICD TRIAL
45. LB-456087-2 CHRONIC SAFETY AND PERFORMANCE OF THE EXTRAVASCULAR ICD: RESULTS FROM THE GLOBAL EV ICD PIVOTAL STUDY
46. Prognosis in Patients with Atrial Fibrillation and CHA2DS2-VASc Score = 0 in a Community-Based Cohort Study
47. Transpulmonary thermodilution and pulse pressure variations in a septic patient with heterotopic cardiac transplantation
48. Left Purkinje premature ventricular complexes following left bundle branch area pacing
49. PO-619-01 SAFETY AND FEASIBILITY OF LEADLESS PACEMAKER IMPLANTATION VIA A LEFT FEMORAL VEIN APPROACH: EXPERIENCE WITH THE MICRA TRANSCATHETER PACEMAKER
50. CI-525-01 EARLY EXPERIENCE WITH A LEADLESS VENTRICULAR PACEMAKER PROVIDING ATRIOVENTRICULAR SYNCHRONOUS PACING IN THE REAL-WORLD SETTING: RESULTS FROM THE MICRA AV POST-APPROVAL REGISTRY
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.